During the past decade, Kamlesh N. Dave Cardiology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kamlesh N. Dave Cardiology" are "Hypertension" (2 trials). Many other conditions were trialed in "Kamlesh N. Dave Cardiology" in a lesser frequency.

Most popular intervention types in "Kamlesh N. Dave Cardiology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials), "Guanfacine" (2 trials) and "Darusentan Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kamlesh N. Dave Cardiology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kamlesh N. Dave Cardiology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kamlesh N. Dave Cardiology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kamlesh N. Dave Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".